[1] |
World Health Organization.Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
|
[2] |
杨春龙, 周林, 陈明亭.《病原学检测阴性肺结核诊断流程(T/CHATA 008—2020)》解读. 中国防痨杂志, 2021, 43(11):1116-1119. doi:10.3969/j.issn.1000-6621.2021.11.003.
|
[3] |
Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn, 2012, 12(2):175-187. doi:10.1586/erm.11.97.
URL
pmid: 22369377
|
[4] |
Qiu X, Tang Y, Yue Y, et al. Accuracy of interferon-γ-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis. Clin Microbiol Infect, 2019, 25(6):667-672. doi:10.1016/j.cmi.2018.12.006.
|
[5] |
Chanyi L, Jing W, Honghai W, et al. Novel Biomarkers Distinguishing Active Tuberculosis from Latent Infection Identified by Gene Expression Profile of Peripheral Blood Mononuclear Cells. PLoS One, 2011, 6(8):e24290. doi:10.1371/journal.pone.0024290.
|
[6] |
Blauenfeldt T, Heyckendorf J, Graff Jensen S, et al. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M.tuberculosis using dried blood spots. PLoS One, 2014, 9(9): e105628. doi:10.1371/journal.pone.0105628.
|
[7] |
Kabeer BS, Raja A, Raman B, et al. IP-10 response to RD 1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis, 2011, 11:135. doi:10.1186/1471-2334-11-135.
|
[8] |
Aabye MG, Ruhwald M, Praygod G, et al. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J, 2010, 36(6):1488-1490. doi:10.1183/09031936.00039010.
URL
pmid: 21119209
|
[9] |
Pan L, Huang M, Jia H, et al. Diagnostic Performance of a Novel CXCL 10 mRNA Release Assay for Mycobacterium tuberculosis Infection. Front Microbiol, 2022, 13: 825413. doi:10.3389/fmicb.2022.825413.
|
[10] |
中华人民共和国国家卫生和计划生育委员会.WS 288—2017 肺结核诊断. 2017-11-09.
|
[11] |
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 385(9963):117-171. doi:10.1016/S0140-6736(14)61682-2.
URL
pmid: 25530442
|
[12] |
Qiu X, Xiong T, Su X, et al. Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis. BMC Infect Dis, 2019, 19(1):924. doi:10.1186/s12879-019-4466-5.
URL
pmid: 31666025
|
[13] |
宋瑞雪, 魏荣荣, 董静, 等. γ-干扰素诱导蛋白-10 mRNA检测技术对结核病辅助诊断的价值. 中国防痨杂志, 2023, 45(5):471-476. doi:10.19982/j.issn.1000-6621.20220518.
|
[14] |
Ting WY, Huang SF, Lee MC, et al. Gender disparities in latent tuberculosis infection in high-risk individuals: a cross-sectional study. PLoS One, 2014, 9(11):e110104. doi:10.1371/journal.pone.0110104.
|
[15] |
Sabri A, Quistrebert J, Naji Amrani H, et al. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco. PLoS One, 2019, 14(8):e0221081. doi:10.1371/journal.pone.0221081.
|
[16] |
Zhang L, Shi X, Zhang Y, et al. Analysis of Factors Influencing Diagnostic Accuracy of T-SPOT.TB for Active Tuberculosis in Clinical Practice. Sci Rep, 2017, 7(1):7764. doi:10.1038/s41598-017-07785-6.
URL
pmid: 28798488
|
[17] |
潘丽萍, 贾红彦, 刘菲, 等. γ-干扰素释放试验对不同年龄组疑似肺结核的辅助诊断价值. 中华结核和呼吸杂志, 2015, 38(12):892-896. doi:10.3760/cma.j.issn.1001-0939.2015.12.005.
|
[18] |
杨新婷, 郭超, 梁清涛, 等. 结核感染T细胞斑点试验检测对老年活动性肺结核的诊断价值. 中国防痨杂志, 2015, 37(7):790-794. doi:10.3969/j.issn.1000-6621.2015.07.015.
|
[19] |
潘丽萍, 高孟秋, 贾红彦, 等. 新型结核分枝杆菌特异性细胞免疫反应检测技术对结核病辅助诊断的价值评估. 中华结核和呼吸杂志, 2021, 44(5):443-449. doi:10.3760/cma.j.cn112147-20200821-00916.
|
[20] |
Santos JA, Duarte R, Nunes C. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis. Pulmonology, 2020, 26(6):353-362. doi:10.1016/j.pulmoe.2019.11.001.
URL
pmid: 31843341
|
[21] |
Henry RT, Jiamsakul A, Law M, et al. Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants. J Acquir Immune Defic Syndr, 2021, 87(1):720-729. doi:10.1097/QAI.0000000000002619.
URL
pmid: 33399309
|
[22] |
Gao L, Bai L, Liu J, et al. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J, 2016, 48(1):168-178. doi:10.1183/13993003.00235-2016.
URL
pmid: 27230438
|
[23] |
Gao L, Li X, Liu J, et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2017, 17(10):1053-1061. doi:10.1016/S1473-3099(17)30402-4.
URL
pmid: 28716677
|
[24] |
García-Goez JF, Vélez JD, Mora BL, et al. Tuberculosis in elderly patients in the city of Cali, Colombia: a hospital-based cohort study. J Bras Pneumol, 2020, 46(5):e20200072. doi:10.36416/1806-3756/e20200072.
|
[25] |
中华医学会结核病学分会. 老年肺结核诊断与治疗专家共识(2023版). 中华结核和呼吸杂志, 2023, 46(11): 1068-1084. doi:10.3760/cma.j.cn112147-20230921-00182.
|
[26] |
Byng-Maddick R, Noursadeghi M. Does tuberculosis threaten our ageing populations?. BMC Infect Dis, 2016, 16:119. doi:10.1186/s12879-016-1451-0.
URL
pmid: 26968654
|